Suchergebnisse - "Scheen, André"

PubPharm (27)

1

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment : The FIDELITY Analysis

enthalten in: Diabetes care | 2022

von Rossing, P. | Anker, S. | Filippatos, G. | +112

CommentIn: Nephrology (Carlton). 2022 Dec;27(12):915-916. - PMID 36273253

2

Focus on tirzepatide, a dual unimolecular GIP-GLP-1 receptor agonist in type 2 diabetes

enthalten in: Revue medicale suisse | 2022

von Scheen, A. | Radermecker, R. | Paquot, N.

3

Interleukin 6 and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Chronic Coronary Syndrome

enthalten in: JAMA cardiology | 2021

von Batra, G. | Ghukasyan Lakic, T. | Lindbäck, J. | +110

4

Once-Weekly Semaglutide in Adults with Overweight or Obesity

enthalten in: The New England journal of medicine | 2021

von Wilding, J. | Batterham, R. | Calanna, S. | +112

CommentIn: N Engl J Med. 2021 Mar 18;384(11):1066-1067. - PMID 33567184

5

Efficacy and Safety of PCSK9 Inhibition With Evolocumab in Reducing Cardiovascular Events in Patients With Metabolic Syndrome Receiving Statin Therapy : Secondary Analysis From the FOURIER Randomized Clinical Trial

enthalten in: JAMA cardiology | 2021

von Deedwania, P. | Murphy, S. | Scheen, A. | +8

6

Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial

enthalten in: American journal of nephrology | 2019

von Ruilope, L. | Agarwal, R. | Anker, S. | +108

7

Increased Risk of Severe Hypoglycemic Events Before and After Cardiovascular Outcomes in TECOS Suggests an At-Risk Type 2 Diabetes Frail Patient Phenotype

enthalten in: Diabetes care | 2018

von Standl, E. | Stevens, S. | Armstrong, P. | +10

8

Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1) : 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial

enthalten in: The lancet. Diabetes & endocrinology | 2017

von Dandona, P. | Mathieu, C. | Phillip, M. | +107

CommentIn: Lancet Diabetes Endocrinol. 2017 Nov;5(11):841-843. - PMID 28919060

9

Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease

enthalten in: The New England journal of medicine | 2017

von Sabatine, M. | Giugliano, R. | Keech, A. | +110

CommentIn: N Engl J Med. 2017 May 4;376(18):1790-1791. - PMID 28304233

10

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes : a randomised, double-blind trial

enthalten in: Lancet (London, England) | 2017

von le Roux, C. | Astrup, A. | Fujioka, K. | +109

CommentIn: Lancet. 2017 Apr 8;389(10077):1371-1372. - PMID 28237265